XiFin
Buying intent
65 tracked signals | Top 15 topics are below | HR is carrying most of it.
Attention by team
LinkedIn activity, by teamWhere XiFin's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
9d ago
10d ago
10d ago
10d ago
12d ago
10d ago
20d ago
20d ago
12d ago
10d ago
19d ago
23d ago
26d ago
20d ago
12d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at XiFin
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
11 people across every department at XiFin, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileXiFin is a healthcare information technology company that empowers healthcare organizations to navigate an increasingly complex and evolving healthcare landscape. Through innovative technologies and consulting services, we deliver operational efficiency, interoperability, and simplicity. Our revenue cycle management and workflow automation solutions enable organizations to achieve stronger finance
Top accounts researching XiFin
names withheld on the public pageThese are companies whose own people brought up XiFin unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
75,708 companies · 411,263 people are researching Hiring
XiFin's own team shows 15 signals on this topic. No one outside XiFin has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Electrical Engineering and Planning1,909 cos · 8,764 people
- Project Manager8,627 cos · 32,471 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Sales — 4 people; Marketing — 1 person; Security — 1 person; Engineering — 1 person
What's been said
public posts by XiFin's teamNo public post naming XiFin has surfaced in the past year, so this is what XiFin's own team is posting about publicly — their topics, in their words.
I’m happy to share that I’ve obtained a new certification, Oxygen Breather. I have now officially started figuring it out. I also realised if I hold my breath for a minute and then breath for a minute that I will have held my breath each day for 12 hours.
May 2026PAMA reporting continues to be one of the most important reimbursement and compliance priorities facing clinical laboratories today. While many organizations view reporting as a regulatory obligation, it also represents a critical opportunity to evaluate data integrity, operational readiness, reimbursement strategy, and long-term financial sustainability. In my latest article published by G2 Intelligence , I outline five key priorities laboratories should focus on during the 2026 PAMA reporting cycle, including applicable laboratory determination, validating private payor data, strengthening reporting workflows, and reducing compliance risk. With increased scrutiny around reporting accuracy and continued industry concern surrounding reimbursement pressure, laboratories that take a proactive and strategic approach will be better positioned moving forward. Read the full article here: https://hubs.li/Q04g73mr0 #ClinicalLaboratories #LaboratoryMedicine #PAMA #HealthcareFinance #RevenueCycleManagement #Diagnostics #LabLeaders #HealthcarePolicy #Medicare #RCM
May 2026